Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Visualizzazioni
• 08/04/23
0
0
Incorporare
administrator
Iscritti
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti